Literature DB >> 2061569

Histiocytosis X of the hypothalamus.

A Tabarin1, J B Corcuff, M Dautheribes, J P Merlio, C Cochet, J P Maire, C Louail, P Roger.   

Abstract

An unusual case of cutaneous and hypothalamic histiocytosis X (HX) is reported. The hypothalamic involvement occurred as a tumor that mimicked a chiasm glioma on computed tomography angioscanning. Magnetic resonance imaging after gadolinium injection localized the tumor within the third ventricle floor. The HX origin of the tumor was confirmed by histological examination of hypothalamic biopsies obtained by transventricular endoscopy. The results of endocrine evaluation were consistent with anterior panhypopituitarism resulting from a multiple releasing-hormone secretory defect, but there was no diabetes insipidus. This unusual endocrine aspect has not been previously described in the field of hypothalamic HX. Lastly, the tumor was insensitive to low dose megavoltage radiation therapy. This unusual case stresses the superiority of magnetic resonance imaging over computed tomography scanning in the assessment of suprasellar tumors and emphasizes the usefulness of transventricular endoscopy in these cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2061569     DOI: 10.1007/BF03350286

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Multifocal eosinophilic granuloma. Natural history, etiology and management.

Authors:  W H Zinkham
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

2.  Isolated histiocytosis X of the hypothalamus. Case report.

Authors:  P A Tibbs; V Challa; R H Mortara
Journal:  J Neurosurg       Date:  1978-12       Impact factor: 5.115

3.  Histiocytosis X in the optic chiasm of an adult with hypopituitarism. Case report.

Authors:  E A Smolik; M Devecerski; J S Nelson; K R Smith
Journal:  J Neurosurg       Date:  1968-09       Impact factor: 5.115

4.  Histiocytosis-X of the hypothalamus: case report and literature review.

Authors:  J R Jinkins
Journal:  Comput Radiol       Date:  1987 Jul-Aug

5.  Neuroendocrinological aspects of histiocytosis X of the central nervous system.

Authors:  B S Sawhny; D F Dohn
Journal:  Surg Neurol       Date:  1980-09

6.  Hypothalamic endocrinopathy in Hand-Schüller-Christian disease.

Authors:  J G Rothman; P J Snyder; R D Utiger
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

7.  CT of the abnormal pituitary stalk.

Authors:  R G Peyster; E D Hoover
Journal:  AJNR Am J Neuroradiol       Date:  1984 Jan-Feb       Impact factor: 3.825

8.  Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.

Authors:  T Williams; M Berelowitz; S N Joffe; M O Thorner; J Rivier; W Vale; L A Frohman
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

9.  Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism.

Authors:  P J Snyder; R S Rudenstein; D F Gardner; J G Rothman
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

10.  The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man.

Authors:  A Masuda; T Shibasaki; M Nakahara; T Imaki; Y Kiyosawa; K Jibiki; H Demura; K Shizume; N Ling
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

View more
  2 in total

1.  Spontaneous gonadotrophin deficiency recovery in an adult patient with Langerhans cell histiocytosis (LCH).

Authors:  Polyzois Makras; Dimitrios Papadogias; George Kontogeorgos; George Piaditis; Gregory A Kaltsas
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Langerhans cell histiocytosis, diabetes insipidus, hyperprolactinemia and empty sella: a four-fold association. Report of two cases.

Authors:  N Panza; B Merola; A Colao; G Iodice; A de Bellis; A Bizzarro; A Bellastella; G Lombardi
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.